AHL Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-7,699
Closed -$242K 755
2015
Q3
$242K Sell
7,699
-3,502
-31% -$171K 0.04% 624
2015
Q2
$542K Sell
11,201
-21,434
-66% -$903K 0.02% 668
2015
Q1
$1.42M Buy
+32,635
New +$1.17M 0.06% 537

Other funds holding PGEN

AHL Partners's PGEN Position: Q4 2015 in Review

AHL Partners sold out of Precigen (PGEN) in Q4 2015, closing a stake of 7,699 shares — an estimated $242K sold.

AHL Partners first reported a position in PGEN in Q1 2015 and held it in 3 quarters. The position peaked at $1.42M in Q1 2015. 180 funds tracked by Wall St. Rank hold PGEN as of Q4 2015.

  • AHL Partners reported no remaining Precigen position as of Q4 2015 after selling out during the quarter.
  • AHL Partners sold 7,699 Precigen shares in Q4 2015, an estimated $242K.
  • AHL Partners first reported a position in Precigen in Q1 2015 and held it in 3 quarters.
  • AHL Partners's Precigen position peaked at $1.42M in Q1 2015.
  • 180 funds tracked by Wall St. Rank held Precigen as of Q4 2015.

Based on AHL Partners's 13F filing for Q4 2015, filed 16 Feb 2016.